Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4 ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Holmgaard, Rikke B.
- Contributor
-
Zamarin, Dmitriy
Munn, David H.
Wolchok, Jedd D.
Allison, James P.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P77
- URN
-
urn:nbn:de:1111-2016072650467
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Holmgaard, Rikke B.
- Zamarin, Dmitriy
- Munn, David H.
- Wolchok, Jedd D.
- Allison, James P.
- SpringerLink (Online service)
Other Objects (12)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success